References
- Tasaka K., Akagi M., Izushi K., Aoki I. Antiallergic effect of epinastine: the elucidation of the mechanism. Oyo Yakuri/Pharmacometries 1990; 39: 365
- Awouters F. H. L., Niemegeers C. J. E., Janssen P. A.J. Pharmacology of the specific histamine H1-antagonist astemizole. Arzneim-Forsch. 1983; 33: 381
- Ohmori K., Ishii H., Nito M., Shuto K., Nakamizo N. Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators. Folia Pharmacol. Japon. 1983; 81: 399
- Criscuoli M., Subissi A., Daffonchio L., Omini C. LG 30435, a new bronchodilator/antiallergic agent, inhibits PAF-acether induced platelet aggregation and bronchoconstriction. Agents Actions 1986; 19: 246
- Kojima M, Tsutsumi N., Abe M., Komatsu H., Ujiie A., Naito J., Nakazawa M. Experimental allergic rhinitis in rats and the influence of tranilast and antihistaminics on it. Jpn. J. Allergol. 1986; 35: 180
- Akagi M., Tasaka K. Analysis of bronchomotor tone in anesthetized guinea pigs by impedance plethysmography: a simple method for the evaluation of bronchodilator action. Meth. Find. Exp. Clin. Pharmacol. 1988; 10: 143
- Bechtel W. D., Mierau J. In vitro biochemical comparison of WAL 801, astemizole, and terfenadine. Boehringer Ingelheim KG Report 1986; 1, U86-0298
- Casals-Stenzel J., Muacevic G., Weber K-H. WEB 2086, a new specific antagonist of platelet activating factor (PAF) in vitro and in vivo. Arch. Pharmac 1986; 334: R44
- Casals-Stenzel J., Muacevic G., Weber K-H. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J. Pharmacol, exp. Ther. 1987; 241: 974
- Lewis A. J., Dervinis A., Chang J. The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation. Agents Actions 1984; 15: 636
- Piper P. J. Formation and actions of leukotrienes. Physiol. Rev. 1984; 64: 744